当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析

瑞康医药

(002589)

  

流通市值:40.42亿  总市值:44.54亿
流通股本:13.66亿   总股本:15.05亿

瑞康医药(002589)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.19亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益568885.28万元,未分配利润29116.16万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1604033.69万元,负债1035148.41万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,756,650,456.757,966,345,576.746,056,194,532.514,031,665,203.8
营业总成本1,764,616,859.728,019,365,853.255,997,705,441.863,997,336,554.85
营业利润23,679,569.8525,532,765.353,336,454.1643,089,470.95
利润总额23,391,966.5841,568,837.5847,113,829.3340,186,049.69
净利润19,435,375.8741,017,810.2652,249,021.3140,551,984.9
其他综合收益----
综合收益总额19,435,375.8741,017,810.2652,249,021.3140,551,984.9
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计11,156,915,614.3111,081,074,502.5511,566,826,407.0510,806,885,888.3
非流动资产合计4,883,421,251.534,931,245,502.474,852,023,626.584,918,382,748.39
资产总计16,040,336,865.8416,012,320,005.0216,418,850,033.6315,725,268,636.69
流动负债合计9,938,781,889.059,933,263,752.4310,157,103,491.079,652,583,801.46
非流动负债合计412,702,208.39384,438,086.22556,476,006.04379,111,335.11
负债合计10,351,484,097.4410,317,701,838.6510,713,579,497.1110,031,695,136.57
归属于母公司股东权益合计5,509,105,629.985,537,791,736.875,506,126,278.25,498,345,289.35
股东权益合计5,688,852,768.45,694,618,166.375,705,270,536.525,693,573,500.12
负债和股东权益合计16,040,336,865.8416,012,320,005.0216,418,850,033.6315,725,268,636.69
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计1,956,956,780.759,594,898,625.866,652,723,709.544,151,118,736.02
经营活动现金流出小计1,913,930,631.999,434,453,746.366,641,294,038.574,141,785,160.86
经营活动产生的现金流量净额43,026,148.76160,444,879.511,429,670.979,333,575.16
投资活动现金流入小计25,039,560.231,061,548,202.41468,658,637.64402,736,256.3
投资活动现金流出小计24,396,079.85857,570,822.17202,318,342.41146,086,352.77
投资活动产生的现金流量净额643,480.38203,977,380.24266,340,295.23256,649,903.53
筹资活动现金流入小计5,436,577,590.8321,358,688,268.9714,973,924,857.428,935,368,955.25
筹资活动现金流出小计5,196,928,207.0421,505,163,072.9115,110,791,313.198,900,592,719.52
筹资活动产生的现金流量净额239,649,383.79-146,474,803.94-136,866,455.7734,776,235.73
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额283,319,012.93217,947,455.8140,903,510.43300,759,714.42
期末现金及现金等价物余额973,208,371.46689,889,358.53612,845,413.16772,701,617.15
TOP↑